Papers - SHIRATORI Toshihiro
-
A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non-small-cell Lung Cancer
Tanaka Hisashi, Hasegawa Yukihiro, Makiguchi Tomonori, Okumura Fumihiko, Tabe Chiori, Shiratori Toshihiro, Ishioka Yoshiko, Itoga Masamichi, Taima Kageaki, Yokouchi Junichi, Hatayama Yoshiomi, Aoki Masahiko, Tasaka Sadatomo
CLINICAL LUNG CANCER 22 ( 1 ) 42 - 48 2021.1
-
ISG56 is involved in CXCL10 expression induced by TLR3 signaling in BEAS-2B bronchial epithelial cells
Shiratori Toshihiro, Imaizumi Tadaatsu, Hirono Koji, Kawaguchi Shogo, Matsumiya Tomoh, Seya Kazuhiko, Tasaka Sadatomo
EXPERIMENTAL LUNG RESEARCH 46 ( 6 ) 195 - 202 2020.7
-
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer
Tanaka Hisashi, Tabe Chiori, Okumura Fumihiko, Shiratori Toshihiro, Ishioka Yoshiko, Itoga Masamichi, Taima Kageaki, Morimoto Takeshi, Kimura Daisuke, Tsushima Takao, Tasaka Sadatomo
THORACIC CANCER 11 ( 6 ) 1633 - 1638 2020.6
-
Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review
Shiratori Toshihiro, Tanaka Hisashi, Tabe Chiori, Tsuchiya Junichiro, Ishioka Yoshiko, Itoga Masamichi, Taima Kageaki, Takanashi Shingo, Tasaka Sadatomo
THORACIC CANCER 11 ( 6 ) 1720 - 1723 2020.6
-
Predictors of efficacy of anamorelin in patients with non-small cell lung cancer and cachexia: A retrospective study
Ishioka Yoshiko, Tanaka Hisashi, Makiguchi Tomonori, Fujishima Syunsuke, Nunomura Yasuhito, Sakamoto Hiroaki, Shiratori Toshihiro, Taima Kageaki, Tasaka Sadatomo
ONCOLOGY LETTERS 27 ( 1 ) 22 2024.1
-
Hypervirulent <i>Klebsiella pneumoniae</i> infection in a patient with coronavirus disease 2019: A case report
Itoga Masamichi, Taima Kageaki, Tanaka Hisashi, Makiguchi Tomonori, Ishioka Yoshiko, Sakamoto Hiroaki, Shiratori Toshihiro, Hayashi Wataru, Kayama Shizuo, Sugai Motoyuki, Tasaka Sadatomo
RESPIROLOGY 28 211 - 211 2023.11
-
Toll-like receptor 3 signaling induces interferon-induced transmembrane protein 1 in BEAS-2B cells
Dobashi Masaki, Shiratori Toshihiro, Imaizumi Tadaatsu, Hashimoto Shun, Kawaguchi Shogo, Seya Kazuhiko, Tasaka Sadatomo
EXPERIMENTAL BIOLOGY AND MEDICINE 247 ( 21 ) 1917 - 1922 2022.11
-
Toll-like receptor 3 signaling induces interferon-induced transmembrane protein 1 in BEAS-2B cells.
Dobashi M, Shiratori T, Imaizumi T, Hashimoto S, Kawaguchi S, Seya K, Tasaka S.
Exp Biol Med 247 1917 - 1922 2022.9
-
The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study
Dobashi Masaki, Tanaka Hisashi, Taima Kageaki, Itoga Masamichi, Ishioka Yoshiko, Shiratori Toshihiro, Okumura Fumihiko, Tabe Chiori, Tanaka Yoshihito, Morimoto Takeshi, Hasegawa Yukihiro, Yasugahira Hideo, Okudera Koichi, Takanashi Shingo, Tasaka Sadatomo
SAGE OPEN MEDICINE 9 20503121211023357 2021.6
-
Endothelial expression of fractalkine (CX3CL1) is induced by Toll-like receptor 3 signaling in cultured human glomerular endothelial cells
Hirono Koji, Imaizumi Tadaatsu, Aizawa Tomomi, Watanabe Shojiro, Tsugawa Koji, Shiratori Toshihiro, Kawaguchi Shogo, Seya Kazuhiko, Matsumiya Tomoh, Ito Etsuro, Tanaka Hiroshi
MODERN RHEUMATOLOGY 30 ( 6 ) 1074 - 1081 2020.11
-
Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia
Tabe Chiori, Shiratori Toshihiro, Ishioka Yoshiko, Itoga Masamichi, Tanaka Hisashi, Taima Kageaki, Takanashi Shingo, Tasaka Sadatomo
EUROPEAN RESPIRATORY JOURNAL 56 2020.9
-
A Case of Methotrexate-Associated Lymphoproliferative Disorders(MTX-LPD) in the Chest Wall Presumably Influenced by Asbestos Exposure
Akita T., Taima K., Tanaka H., Itoga M., Ishioka Y., Baba K., Shiratori T., Tsuchiya J., Tabe C., Suzuki S., Takanashi S., Tasaka S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 201 2020
-
A Case of Large Cell Neuroendocrine Carcinoma Successfully Treated with Nivolumab
Tabe Chiori, Tanaka Hisashi, Taima Kageaki, Itoga Masamichi, Shiratori Toshihiro, Tasaka Sadatomo
Haigan 59 ( 7 ) 1156 - 1161 2019.12
-
The Impact of Radiation Pneumonitis on Prognosis of Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
Akita T., Baba K., Tanaka H., Fujioka I., Suzuki S., Tabe C., Shiratori T., Ishioka Y., Itoga M., Taima K., Yokouchi J., Hasegawa Y., Takanashi S., Tasaka S.
JOURNAL OF THORACIC ONCOLOGY 14 ( 10 ) S636 - S636 2019.10
-
The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations.
Hiroaki Sakamoto, Hisashi Tanaka, Toshihiro Shiratori, Keisuke Baba, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Yukihiro Hasegawa, Shingo Takanashi, Sadatomo Tasaka
Molecular and clinical oncology 10 ( 6 ) 610 - 614 2019.6
-
The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations
Sakamoto Hiroaki, Tanaka Hisashi, Shiratori Toshihiro, Baba Keisuke, Ishioka Yoshiko, Itoga Masamichi, Taima Kageaki, Hasegawa Yukihiro, Takanashi Shingo, Tasaka Sadatomo
MOLECULAR AND CLINICAL ONCOLOGY 10 ( 6 ) 610 - 614 2019.6
-
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer
Tanaka Hisashi, Taima Kageaki, Itoga Masamichi, Ishioka Yoshiko, Baba Keisuke, Shiratori Toshihiro, Sakamoto Hiroaki, Tsuchiya Junichiro, Nakagawa Hideyuki, Hasegawa Yukihiro, Yasugahira Hideo, Okudera Koichi, Takanashi Shingo, Tasaka Sadatomo
MEDICAL ONCOLOGY 36 ( 6 ) 57 2019.6
-
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer.
Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka, Keisuke Baba, Toshihiro Shiratori, Hiroaki Sakamoto, Junichiro Tsuchiya, Hideyuki Nakagawa, Yukihiro Hasegawa, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Medical oncology (Northwood, London, England) 36 ( 6 ) 57 - 57 2019.5
-
Efficacy of pembrolizumab for patients with both high PD-L1 expression and an MET exon 14 skipping mutation: A case report.
Keisuke Baba, Hisashi Tanaka, Hiroaki Sakamoto, Toshihiro Shiratori, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Sadatomo Tasaka
Thoracic cancer 10 ( 2 ) 369 - 372 2019.2
-
Efficacy of pembrolizumab for patients with both high PD-L1 expression and an MET exon 14 skipping mutation: A case report
Baba Keisuke, Tanaka Hisashi, Sakamoto Hiroaki, Shiratori Toshihiro, Tsuchiya Junichiro, Ishioka Yoshiko, Itoga Masamichi, Taima Kageaki, Tasaka Sadatomo
THORACIC CANCER 10 ( 2 ) 369 - 372 2019.2